Albireo Pharma, Inc.
ALBO · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $248,107 | $251,272 | $131,843 | $163,885 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3,272 | $0 | $0 | $2,915 |
| Inventory | $194 | $0 | $0 | $0 |
| Other Curr. Assets | $17,357 | $10,593 | $9,956 | $850 |
| Total Curr. Assets | $268,930 | $261,865 | $141,799 | $167,650 |
| Property Plant & Equip (Net) | $668 | $478 | $597 | $187 |
| Goodwill | $17,260 | $17,260 | $17,260 | $17,260 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $15,193 | $6,004 | $5,413 | $369 |
| Total NC Assets | $33,121 | $23,742 | $23,270 | $17,816 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $302,051 | $285,607 | $165,069 | $185,466 |
| Liabilities | – | – | – | – |
| Payables | $6,516 | $5,283 | $4,785 | $4,352 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $38,831 | $19,999 | $14,139 | $8,473 |
| Total Curr. Liab. | $45,347 | $25,282 | $18,924 | $12,825 |
| LT Debt | $10,004 | $9,621 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $71,092 | $69,473 | $52,984 | $50,004 |
| Total NC Liab. | $81,096 | $79,094 | $52,984 | $50,004 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $126,443 | $104,376 | $71,908 | $62,829 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $193 | $191 | $127 | $120 |
| Retained Earnings | -$300,850 | -$266,820 | -$159,187 | -$96,470 |
| AOCI | $1,105 | -$8,612 | $6,452 | $4,293 |
| Other Equity | $475,160 | $456,472 | $245,769 | $214,694 |
| Total Equity | $175,608 | $181,231 | $93,161 | $122,637 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $302,051 | $285,607 | $165,069 | $185,466 |
| Net Debt | -$238,103 | -$241,651 | -$131,843 | -$163,885 |